Use this dropdown to select your preferred language.
Boehringer Ingelheim is one of the world’s top 20 pharma companies. The company operates globally with 145 affiliates and more than 50,000 employees. For 130 years in the world and 60 years in Brazil, the family-owned company has been committed to researching, developing, manufacturing and marketing new drugs of high therapeutic value for human and veterinary medicine. Respect, equity and a balance between career and family life form our basis.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
In Italy Boehringer Ingelheim is present in:
Milan the headquarters, the Human Pharma Business Unit and Boehringer Ingelheim Animal Health Italia
Fornovo San Giovanni (BG), headquarters of Bidachem SpA, the strategic API production plant of the Group worldwide,
Noventa Padovana (PD), the production site for veterinary vaccines.
In Italy Clinical Operations group has a focus on cardiometabolic, respiratory, immunological and oncological areas
Boehringer Ingelheim has been committed to providing innovative treatments in Human and Animal Health for over 130 years. Boehringer Ingelheim is a family-owned, R&D-driven company and one of the top 20 pharmaceutical companies in the world. Our employees create value through innovation in Human Health, Animal Health and contract manufacturing of biopharmaceuticals.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term sustainable perspective.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
At Boehringer Ingelheim, the development of medicines for people and animals is at the heart of our work. Our mission is to develop innovative therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been an independent family company. We are free to pursue our long-term vision, anticipating the health challenges of the future and targeting those areas of need where we can deliver the greatest benefits
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.